Your browser doesn't support javascript.
loading
Reduced Plasma Selenoprotein P Is Associated With Type I Antithrombin Deficiency and a Prothrombotic State.
Klajmon, Adrianna; Natorska, Joanna; Corral, Javier; de la Morena-Barrio, Maria Eugenia; Bravo-Pérez, Carlos; Kopytek, Magdalena; Jankowska, Urszula; Skupien-Rabian, Bozena; Hanarz, Maksymilian; Trelinski, Jacek; Zabczyk, Michal.
Afiliação
  • Klajmon A; From Krakow Centre for Medical Research and Technologies, St. John Paul II Hospital, Kraków, Poland (Klajmon, Natorska, Kopytek, Zabczyk).
  • Natorska J; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland (Klajmon, Jankowska, Skupien-Rabian).
  • Corral J; From Krakow Centre for Medical Research and Technologies, St. John Paul II Hospital, Kraków, Poland (Klajmon, Natorska, Kopytek, Zabczyk).
  • de la Morena-Barrio ME; the Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland (Natorska, Kopytek, Hanarz, Zabczyk).
  • Bravo-Pérez C; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, IMIB, CIBERER-ISCIII, Universidad de Murcia, Murcia, Spain (Corral, de la Morena-Barrio, Bravo-Pérez).
  • Kopytek M; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, IMIB, CIBERER-ISCIII, Universidad de Murcia, Murcia, Spain (Corral, de la Morena-Barrio, Bravo-Pérez).
  • Jankowska U; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, IMIB, CIBERER-ISCIII, Universidad de Murcia, Murcia, Spain (Corral, de la Morena-Barrio, Bravo-Pérez).
  • Skupien-Rabian B; From Krakow Centre for Medical Research and Technologies, St. John Paul II Hospital, Kraków, Poland (Klajmon, Natorska, Kopytek, Zabczyk).
  • Hanarz M; the Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland (Natorska, Kopytek, Hanarz, Zabczyk).
  • Trelinski J; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland (Klajmon, Jankowska, Skupien-Rabian).
  • Zabczyk M; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland (Klajmon, Jankowska, Skupien-Rabian).
Arch Pathol Lab Med ; 2024 Sep 13.
Article em En | MEDLINE | ID: mdl-39265995
ABSTRACT
CONTEXT.­ A positive association between antithrombin activity and selenium level was reported. Selenoprotein P, the most important selenium carrier, was identified within human plasma fibrin clots. OBJECTIVE.­ To investigate the relationship between selenoprotein P and antithrombin and its role in modulation of fibrin clot properties in antithrombin-deficient patients. DESIGN.­ Proteomic analysis of plasma fibrin clots was performed with mass spectrometry. In 108 patients with genetically confirmed type I (57%) or type II (43%) antithrombin deficiency and in healthy controls (n = 50), we assessed plasma selenoprotein P levels and thiobarbituric acid-reactive substances by enzyme-linked immunosorbent assay, along with fibrin clot permeability, clot lysis time, and thrombin generation. RESULTS.­ Clot-bound antithrombin concentration was 0.46 ± 0.32 mg/g protein, while selenoprotein P level was 30-fold lower (0.015 ± 0.012 mg/g). Type I compared to type II antithrombin-deficient patients had higher clot-bound antithrombin and selenoprotein P levels (both P < .001), associated together (ρ = 0.93, P < .001). Individuals with type I compared to type II antithrombin deficiency or controls had about 40% lower plasma selenoprotein P levels (P < .001). In antithrombin-deficient patients, plasma selenoprotein P was associated with antithrombin antigen (ρ = 0.35, P < .001) and thiobarbituric acid-reactive substances (ρ = 0.42, P < .001). Plasma selenoprotein P correlated also with endogenous thrombin potential (r = -0.33, P < .001), fibrin clot permeability (r = 0.43, P < .001), and clot lysis time (r = -0.40, P < .001) in antithrombin-deficient patients but not in controls. CONCLUSIONS.­ Patients with type I antithrombin deficiency had higher clot-bound selenoprotein P and reduced plasma selenoprotein P levels. Plasma selenoprotein P was associated with prothrombotic fibrin clot phenotype and enhanced thrombin generation.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article